The Manhattan Institute Center has published a report 'Trial Lawyers, Inc.: Health Care ' examines the impact of the "litigation industry" on health care. This is the third in a series of reports published by the center on 'Trial Lawyers, Inc."
The report finds that litigation is a large contributor to the health care bill, and pharmaceutical litigation also exacts a staggering cost on the economy. Litigation exposure is many times more than the annual research and development budgets of the pharmaceutical companies. Litigation has targeted all levels of health care, including nonprofit hospitals, nursing homes and managed-care providers.
Malpractice suits have inflated the cost of health care by encouraging "defensive medicine" - unnecessary procedures and referrals that doctors prescribe in order to limit their liability.
Product liability lawsuits are also frightening companies away from innovations that would lead to health improvements, not only for American society, but for the entire world.
Finally, the report concludes that medical litigation hardly protects or compensates the actual victims, who often receive less than 50% of the damages, the rest going to lawyers and administrative fees.
Read "Harvard Study Finds 40% Malpractice Suits Baseless" posted on May 11.
Read the Manhattan Institute Center report